Used in research to study the activation of soluble guanylyl cyclase (sGC), leading to increased levels of cyclic guanosine monophosphate (cGMP) in cells. This mechanism is explored for potential cardiovascular effects, including vasodilation and inhibition of platelet aggregation. Investigated for possible therapeutic roles in conditions involving impaired sGC activity, such as pulmonary hypertension and erectile dysfunction. Also used as a pharmacological tool to understand cGMP signaling pathways in cellular and animal models.